(Q40147237)

17 September 2017

From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs (English)

1 reference

17 September 2017

From experiment to experience: Side effects of nonsteroidal anti-inflammatory drugs (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

2 October 2023

author name string

L. S. Coles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340495

2 October 2023

J. F. Fries

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340495

2 October 2023

R. G. Kraines

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340495

2 October 2023

S. H. Roth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340495

2 October 2023

language of work or name

English

0 references

publication date

1 May 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0002934383910732?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

https://api.elsevier.com/content/article/PII:0002934383910732?httpAccept=text/plain

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

American Journal of Medicine

2 October 2023

published in

1 reference

17 September 2017

74

1 reference

17 September 2017

820-828

1 reference

17 September 2017

5

1 reference

Prevalence of rheumatic disease

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

Characteristics of respondents and non-respondents to a mailed questionnaire

2 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

Naproxen in rheumatoid arthritis. A controlled trial

2 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

Choline magnesium trisalicylate versus ibuprofen in rheumatoid arthritis

2 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

A six-month double-blind trial of ibuprofen and indomethacin in osteoarthritis

2 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

Fenoprofen calcium in rheumatoid arthritis. A controlled double-blind crossover evaluation

2 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

Fenoprofen in rheumatoid arthritis: a controlled crossover multi-centre study

2 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

Controlled evaluation of fenoprofen in geriatric patients with osteoarthritis

2 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

A multicenter trial of sulindac in osteoarthritis of the hip.

2 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

A patient-administered questionnaire for arthritis assessment

2 October 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

Creative penmanship in animal testing prompts FDA controls

2 October 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

Food and Drug Administration's adverse drug reaction monitoring program

2 October 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

A method for post-marketing screening of adverse reactions to drugs: initial results.

2 October 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents

2 October 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)91073-2

2 October 2023

Identifiers

1 reference

17 September 2017

1 reference